AIM Vaccine Co., Ltd. (6660.HK)

HKD 6.09

(-1.62%)

Long Term Debt Summary of AIM Vaccine Co., Ltd.

  • AIM Vaccine Co., Ltd.'s latest annual long term debt in 2023 was 569.36 Million CNY , up 54.45% from previous year.
  • AIM Vaccine Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 462.9 Million CNY , down -16.88% from previous quarter.
  • AIM Vaccine Co., Ltd. reported annual long term debt of 368.63 Million CNY in 2022, up 62.99% from previous year.
  • AIM Vaccine Co., Ltd. reported annual long term debt of 226.16 Million CNY in 2021, up 384.44% from previous year.
  • AIM Vaccine Co., Ltd. reported quarterly long term debt of 569.36 Million CNY for 2023 FY, up 54.45% from previous quarter.
  • AIM Vaccine Co., Ltd. reported quarterly long term debt of 666.18 Million CNY for 2023 Q2, up 80.72% from previous quarter.

Annual Long Term Debt Chart of AIM Vaccine Co., Ltd. (2023 - 2019)

Historical Annual Long Term Debt of AIM Vaccine Co., Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 569.36 Million CNY 54.45%
2022 368.63 Million CNY 62.99%
2021 226.16 Million CNY 384.44%
2020 46.68 Million CNY 0.0%
2019 - CNY 0.0%

Peer Long Term Debt Comparison of AIM Vaccine Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD -1759.954%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 86.675%